ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
578 hedge funds and large institutions have $35.6B invested in Alexion Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 214 increasing their positions, 199 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 214 | Existing positions reduced: 199
7% less call options, than puts
Call options by funds: $156M | Put options by funds: $168M
Holders
578
Holding in Top 10
18
Calls
$156M
Puts
$168M
Top Buyers
| 1 | +$378M | |
| 2 | +$115M | |
| 3 | +$91.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$86.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$82M |
Top Sellers
| 1 | -$479M | |
| 2 | -$335M | |
| 3 | -$175M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$87.1M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$63.5M |